Carisma Therapeutics, Inc. ( CARM) - Key Metrics
CARM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $1.08 | $1.07 | $0.05 | $0.05 |
| 2025Q2 | $0 | -$0.23 | -$0.14 | -$0.14 |
| 2025Q1 | $0.09 | -$0.22 | -$0.24 | -$0.24 |
| 2024Q4 | $0.09 | -$0.43 | -$0.20 | -$0.20 |
| 2024Q3 | $0.08 | -$0.31 | -$0.31 | -$0.31 |
CARM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 0% | 0.06 |
| 2025Q2 | 0% | -0.43 |
| 2025Q1 | 0% | -0.35 |
| 2024Q4 | 0% | -0.25 |
| 2024Q3 | 0% | -0.79 |
CARM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 16.66% | 0% |
| 2025Q2 | -36.08% | 0% |
| 2025Q1 | -77.74% | 0% |
| 2024Q4 | -48.11% | 0% |
| 2024Q3 | -31.93% | 0% |
CARM
Price: $0
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 0.01
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 96243